Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy

The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects. This study included 245 T2DM patien...

Full description

Saved in:
Bibliographic Details
Published inClinica chimica acta Vol. 455; pp. 113 - 117
Main Authors Zhou, Zhong-Wei, Ju, Hui-Xiang, Sun, Ming-Zhong, Fu, Qing-Ping, Chen, Hong-Mei, Ji, Hong-Bin, Ji, Fei, Jiang, Dong-Mei
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.04.2016
Subjects
Online AccessGet full text
ISSN0009-8981
1873-3492
1873-3492
DOI10.1016/j.cca.2016.02.003

Cover

Abstract The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects. This study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured. Significant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR. Serum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects. •Fetuin-A was positively correlated with VEGF and CRP in T2DM patients.•VEGF was positively correlated with CRP in T2DM patients.•Fetuin-A was independently related with VEGF and CRP in DR patients, but not in NDR.•DR patients had higher HOMA-IR compared with NDR and control subjects.
AbstractList The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects.BACKGROUNDThe higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects.This study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured.METHODSThis study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured.Significant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR.RESULTSSignificant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR.Serum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects.CONCLUSIONSSerum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects.
The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects. This study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured. Significant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR. Serum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects.
The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM). Fetuin-A is shown to have proangiogenic and proinflammatory effects. This study included 245 T2DM patients consisting of 95 cases with non-diabetic retinopathy (NDR), 78 cases with non-proliferative diabetic retinopathy (NPDR) and 72 cases with proliferative diabetic retinopathy (PDR), in addition to 65 healthy controls. Serum fetuin-A, VEGF and CRP concentrations and related parameters were measured. Significant positive correlations were found between fetuin-A and VEGF and CRP, and between VEGF and CRP in T2DM patients (all p<0.001). After adjustment for confounders, fetuin-A was correlated independently with VEGF and CRP in NPDR and PDR patients, but not in NDR subjects. In addition, fetuin-A was correlated independently with HOMA-IR (all 4 groups), HbA1c (NDR, NPDR and PDR groups) and duration of diabetes (PDR group). When compared with NDR and control subjects, NPDR and PDR patients had higher HOMA-IR. Serum fetuin-A concentrations are independently correlated with VEGF and CRP concentrations in T2DM patients with DR, but not in NDR subjects. •Fetuin-A was positively correlated with VEGF and CRP in T2DM patients.•VEGF was positively correlated with CRP in T2DM patients.•Fetuin-A was independently related with VEGF and CRP in DR patients, but not in NDR.•DR patients had higher HOMA-IR compared with NDR and control subjects.
Author Ji, Fei
Sun, Ming-Zhong
Chen, Hong-Mei
Zhou, Zhong-Wei
Ju, Hui-Xiang
Jiang, Dong-Mei
Fu, Qing-Ping
Ji, Hong-Bin
Author_xml – sequence: 1
  givenname: Zhong-Wei
  surname: Zhou
  fullname: Zhou, Zhong-Wei
  organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China
– sequence: 2
  givenname: Hui-Xiang
  surname: Ju
  fullname: Ju, Hui-Xiang
  email: jhxycsy@163.com
  organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China
– sequence: 3
  givenname: Ming-Zhong
  surname: Sun
  fullname: Sun, Ming-Zhong
  organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China
– sequence: 4
  givenname: Qing-Ping
  surname: Fu
  fullname: Fu, Qing-Ping
  organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China
– sequence: 5
  givenname: Hong-Mei
  surname: Chen
  fullname: Chen, Hong-Mei
  organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China
– sequence: 6
  givenname: Hong-Bin
  surname: Ji
  fullname: Ji, Hong-Bin
  organization: Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China
– sequence: 7
  givenname: Fei
  surname: Ji
  fullname: Ji, Fei
  organization: Department of Ophthalmology, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China
– sequence: 8
  givenname: Dong-Mei
  surname: Jiang
  fullname: Jiang, Dong-Mei
  organization: Department of Endocrinology, Affiliated Yancheng Hospital, School of Medicine, Southeast University, Yancheng, Jiangsu 224001, PR China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26851648$$D View this record in MEDLINE/PubMed
BookMark eNp9UctuFDEQtFAQ2QQ-gAvykcsM9tjzEqdoxUuKxAE4Wx67h_XKaw-2Z6P9Mb6PDptw4JBL2-2uqraqrshFiAEIec1ZzRnv3u1rY3Td4LVmTc2YeEY2fOhFJeTYXJANY2yshnHgl-Qq5z22knX8BblsuqHlnRw25Pc3SOuBzlBWF6ob6uEIPlOdgLpgYQEsofgTNTEl8LqApXeu7OhRZ7N6nSgiYtmBd9rTnyne4WzWpsREdbB0WyXAzh2BLikWcAGVgkHNpIuLIeMaWk4L0IZapycoztAFR4jI503_nhPWEHG4O70kz2ftM7x6OK_Jj48fvm8_V7dfP33Z3txWRrSiVF1rezG2gkne98yMBibZWpDQTYMd7SRlP0o763megbXNJGY7DrNoWd-YptdSXJO3Z138_K8VclEHlw14rwPENSuUlbztR94i9M0DdJ0OYNWS3EGnk3r0GgH9GWBSzDnBrIwrf01AL5xXnKn7VNVeYarqPlXFGoWpIpP_x3wUf4rz_szBOOHoIKls0FQD1iUwRdnonmD_AZSSvsA
CitedBy_id crossref_primary_10_1007_s40200_024_01533_0
crossref_primary_10_1016_j_dsx_2019_07_026
crossref_primary_10_1016_j_tibtech_2016_12_006
crossref_primary_10_1016_j_cyto_2017_10_028
crossref_primary_10_1007_s13410_024_01422_5
crossref_primary_10_1016_j_aca_2022_340169
crossref_primary_10_1007_s12020_017_1383_5
crossref_primary_10_1016_j_ajo_2017_12_022
crossref_primary_10_1155_2019_9401628
crossref_primary_10_1177_09287329241295877
crossref_primary_10_3390_proteomes8030025
crossref_primary_10_1007_s40618_017_0697_8
crossref_primary_10_3389_fimmu_2018_01302
crossref_primary_10_4236_ojoph_2017_72011
crossref_primary_10_1080_02713683_2023_2276683
crossref_primary_10_1186_s43162_022_00152_6
crossref_primary_10_1097_MEG_0000000000001354
crossref_primary_10_4103_1673_5374_350192
Cites_doi 10.1007/s00125-014-3177-0
10.1016/j.phrs.2015.05.013
10.1111/j.1464-5491.2007.02217.x
10.1111/j.1582-4934.2005.tb00379.x
10.2337/dc10-0788
10.1016/j.metabol.2014.03.008
10.1016/j.preteyeres.2011.05.002
10.1007/BF00280883
10.1016/j.ajo.2009.07.007
10.1080/09286580601139220
10.3109/1354750X.2012.762806
10.1038/hr.2009.8
10.1016/j.exer.2006.01.016
10.1002/path.4403
10.12659/MSM.893403
10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
10.1167/iovs.11-9119
10.2337/dc12-1591
10.2337/diacare.29.04.06.dc05-1938
10.1016/j.cca.2015.03.030
10.1189/jlb.1205718
10.3892/mmr.2015.3800
10.1155/2014/790902
10.1007/s10238-009-0084-7
10.1111/dme.12274
10.1371/journal.pone.0001765
10.1038/nm.2851
10.1507/endocrj.EJ15-0152
10.2174/1566524014666140128114414
ContentType Journal Article
Copyright 2016 Elsevier B.V.
Copyright © 2016 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2016 Elsevier B.V.
– notice: Copyright © 2016 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.cca.2016.02.003
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1873-3492
EndPage 117
ExternalDocumentID 26851648
10_1016_j_cca_2016_02_003
S0009898116300468
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29B
4.4
457
4G.
5GY
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AAOAW
AAQFI
AAXUO
ABBQC
ABFRF
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABUDA
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
K-O
KOM
L7B
LCYCR
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
RNS
ROL
RPZ
SDF
SDG
SDP
SES
SPCBC
SSH
SSU
SSZ
T5K
WH7
ZA5
~02
~G-
.55
.GJ
53G
AALRI
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABDPE
ABFNM
ABWVN
ABXDB
ACIEU
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRDE
AGRNS
AHHHB
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
CITATION
FEDTE
FGOYB
G-2
HLW
HVGLF
HZ~
J5H
R2-
SBG
SEW
WUQ
X7M
XPP
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFKBS
ID FETCH-LOGICAL-c353t-65d73953041770c9ceb45de4e6b8d9db44794dfafffe052b3fd98f35072c27a43
IEDL.DBID AIKHN
ISSN 0009-8981
1873-3492
IngestDate Fri Sep 05 06:24:58 EDT 2025
Thu Apr 03 07:02:34 EDT 2025
Tue Jul 01 03:31:50 EDT 2025
Thu Apr 24 23:00:00 EDT 2025
Fri Feb 23 02:24:04 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Diabetic retinopathy
Fetuin-A
C-reactive protein
Type 2 diabetes mellitus
Vascular endothelial growth factor
Language English
License Copyright © 2016 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c353t-65d73953041770c9ceb45de4e6b8d9db44794dfafffe052b3fd98f35072c27a43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26851648
PQID 1774157915
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1774157915
pubmed_primary_26851648
crossref_citationtrail_10_1016_j_cca_2016_02_003
crossref_primary_10_1016_j_cca_2016_02_003
elsevier_sciencedirect_doi_10_1016_j_cca_2016_02_003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-04-01
2016-04-00
2016-Apr-01
20160401
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 04
  year: 2016
  text: 2016-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Clinica chimica acta
PublicationTitleAlternate Clin Chim Acta
PublicationYear 2016
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Tang, Kern (bb0025) 2011; 30
Stefan, Hennige, Staiger, Machann, Schick, Krober (bb0150) 2006; 29
Zhang, Wang, Schachat, Bao, Gillies (bb0035) 2014; 14
Zhao, Lin, Wu, Luo, Fan, Dong (bb0105) 2013; 18
Lorant, Grujicic, Hoebaus, Brix, Hoellerl, Schernthaner (bb0110) 2011; 34
Nowak, Wielkoszynski, Marek, Kos-Kudla, Swietochowska, Sieminska (bb0030) 2010; 10
Pal, Dasgupta, Kundu, Maitra, Das, Mukhopadhyay (bb0135) 2012; 18
Zittermann, Issekutz (bb0090) 2006; 80
Hennige, Staiger, Wicke, Machicao, Fritsche, Haring (bb0050) 2008; 3
Rajamani, Jialal (bb0130) 2014; 2014
Liu, Hamnvik, Chamberland, Petrou, Gong, Christophi (bb0160) 2014; 63
Byrne, Bouchier-Hayes, Harmey (bb0020) 2005; 9
Zhao, Hou, Wang, Jiang (bb0120) 2015; 21
Anan, Takayuki, Takahashi, Nakagawa, Eshima, Saikawa (bb0140) 2009; 32
Nakao, Arima, Ishikawa, Kohno, Kawahara, Miyazaki (bb0040) 2012; 53
Jensen, Bartz, Mukamal, Djousse, Kizer, Tracy (bb0125) 2013; 36
Noort, van Zoest, Weijers, Koolwijk, Maracle, Novack (bb0100) 2014; 234
Xiao, Jia, Zhang, Wei, Wang, Wu (bb0095) 2015; 12
Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (bb0075) 1985; 28
Tung, Shih, Tsai, Chou, Chen, Lee (bb0145) 2007; 14
Spijkerman, Gall, Tarnow, Twisk, Lauritzen, Lund-Andersen (bb0010) 2007; 24
Yin, Cai, Zhu, Li, Su, Wang (bb0155) 2015; 8
Siegel-Axel, Ullrich, Stefan, Rittig, Gerst, Klingler (bb0055) 2014; 57
Echouffo-Tcheugui, Ali, Roglic, Hayward, Narayan (bb0005) 2013; 30
Behl, Kotwani (bb0015) 2015; 99
Ou, Lu, Wu, Hung, Wu, Yang (bb0115) 2015; 445
Srinivas, Wagner, Reddy, Deutsch, Leon, Goustin (bb0045) 1993; 7
Arjamaa, Nikinmaa (bb0080) 2006; 83
Zhou, Ju, Sun, Chen, Ji, Jiang (bb0060) 2015; 62
Wang, Wang, Wang (bb0085) 2009; 148
Alberti, Zimmet (bb0065) 1998; 15
Jian-gao (bb0070) 2010; 18
Siegel-Axel (10.1016/j.cca.2016.02.003_bb0055) 2014; 57
Stefan (10.1016/j.cca.2016.02.003_bb0150) 2006; 29
Srinivas (10.1016/j.cca.2016.02.003_bb0045) 1993; 7
Jensen (10.1016/j.cca.2016.02.003_bb0125) 2013; 36
Zhao (10.1016/j.cca.2016.02.003_bb0105) 2013; 18
Behl (10.1016/j.cca.2016.02.003_bb0015) 2015; 99
Tung (10.1016/j.cca.2016.02.003_bb0145) 2007; 14
Zhao (10.1016/j.cca.2016.02.003_bb0120) 2015; 21
Nowak (10.1016/j.cca.2016.02.003_bb0030) 2010; 10
Byrne (10.1016/j.cca.2016.02.003_bb0020) 2005; 9
Pal (10.1016/j.cca.2016.02.003_bb0135) 2012; 18
Zhou (10.1016/j.cca.2016.02.003_bb0060) 2015; 62
Jian-gao (10.1016/j.cca.2016.02.003_bb0070) 2010; 18
Xiao (10.1016/j.cca.2016.02.003_bb0095) 2015; 12
Wang (10.1016/j.cca.2016.02.003_bb0085) 2009; 148
Noort (10.1016/j.cca.2016.02.003_bb0100) 2014; 234
Zittermann (10.1016/j.cca.2016.02.003_bb0090) 2006; 80
Echouffo-Tcheugui (10.1016/j.cca.2016.02.003_bb0005) 2013; 30
Liu (10.1016/j.cca.2016.02.003_bb0160) 2014; 63
Rajamani (10.1016/j.cca.2016.02.003_bb0130) 2014; 2014
Yin (10.1016/j.cca.2016.02.003_bb0155) 2015; 8
Ou (10.1016/j.cca.2016.02.003_bb0115) 2015; 445
Hennige (10.1016/j.cca.2016.02.003_bb0050) 2008; 3
Matthews (10.1016/j.cca.2016.02.003_bb0075) 1985; 28
Lorant (10.1016/j.cca.2016.02.003_bb0110) 2011; 34
Alberti (10.1016/j.cca.2016.02.003_bb0065) 1998; 15
Nakao (10.1016/j.cca.2016.02.003_bb0040) 2012; 53
Arjamaa (10.1016/j.cca.2016.02.003_bb0080) 2006; 83
Zhang (10.1016/j.cca.2016.02.003_bb0035) 2014; 14
Spijkerman (10.1016/j.cca.2016.02.003_bb0010) 2007; 24
Tang (10.1016/j.cca.2016.02.003_bb0025) 2011; 30
Anan (10.1016/j.cca.2016.02.003_bb0140) 2009; 32
References_xml – volume: 30
  start-page: 343
  year: 2011
  end-page: 358
  ident: bb0025
  article-title: Inflammation in diabetic retinopathy
  publication-title: Prog. Retin. Eye Res.
– volume: 8
  start-page: 991
  year: 2015
  end-page: 999
  ident: bb0155
  article-title: Association of plasma fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus
  publication-title: Int. J. Clin. Exp. Med.
– volume: 445
  start-page: 133
  year: 2015
  end-page: 138
  ident: bb0115
  article-title: Both diabetes and fetuin-A are independently associated with increased risk of arterial stiffness
  publication-title: Clin. Chim. Acta
– volume: 148
  start-page: 883
  year: 2009
  end-page: 889
  ident: bb0085
  article-title: Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy
  publication-title: Am J. Ophthalmol.
– volume: 36
  start-page: 1222
  year: 2013
  end-page: 1228
  ident: bb0125
  article-title: Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study
  publication-title: Diabetes Care
– volume: 14
  start-page: 376
  year: 2014
  end-page: 384
  ident: bb0035
  article-title: Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema
  publication-title: Curr. Mol. Med.
– volume: 83
  start-page: 473
  year: 2006
  end-page: 483
  ident: bb0080
  article-title: Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors
  publication-title: Exp. Eye Res.
– volume: 32
  start-page: 299
  year: 2009
  end-page: 305
  ident: bb0140
  article-title: Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients
  publication-title: Hypertens. Res.
– volume: 12
  start-page: 3315
  year: 2015
  end-page: 3322
  ident: bb0095
  article-title: Inflammation and oxidative stress, rather than hypoxia, are predominant factors promoting angiogenesis in the initial phases of atherosclerosis
  publication-title: Mol. Med. Rep.
– volume: 80
  start-page: 247
  year: 2006
  end-page: 257
  ident: bb0090
  article-title: Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation
  publication-title: J. Leukoc. Biol.
– volume: 30
  start-page: 1272
  year: 2013
  end-page: 1292
  ident: bb0005
  article-title: Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review
  publication-title: Diabet. Med.
– volume: 14
  start-page: 148
  year: 2007
  end-page: 154
  ident: bb0145
  article-title: A community-based study of the relationship between insulin resistance/beta-cell dysfunction and diabetic retinopathy among type II diabetics in Kinmen, Taiwan
  publication-title: Ophthalmic Epidemiol.
– volume: 3
  year: 2008
  ident: bb0050
  article-title: Fetuin-A induces cytokine expression and suppresses adiponectin production
  publication-title: PLoS One
– volume: 18
  start-page: 163
  year: 2010
  end-page: 166
  ident: bb0070
  article-title: Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition
  publication-title: Zhonghua Gan Zang Bing Za Zhi
– volume: 34
  start-page: 156
  year: 2011
  end-page: 161
  ident: bb0110
  article-title: Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease
  publication-title: Diabetes Care
– volume: 63
  start-page: 773
  year: 2014
  end-page: 782
  ident: bb0160
  article-title: Circulating alanine transaminase (ALT) and gamma-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus metabolism study
  publication-title: Metabolism
– volume: 9
  start-page: 777
  year: 2005
  end-page: 794
  ident: bb0020
  article-title: Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF)
  publication-title: J. Cell. Mol. Med.
– volume: 53
  start-page: 4323
  year: 2012
  end-page: 4328
  ident: bb0040
  article-title: Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis
  publication-title: Invest. Ophthalmol. Vis. Sci.
– volume: 29
  start-page: 853
  year: 2006
  end-page: 857
  ident: bb0150
  article-title: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans
  publication-title: Diabetes Care
– volume: 7
  start-page: 1445
  year: 1993
  end-page: 1455
  ident: bb0045
  article-title: Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level
  publication-title: Mol. Endocrinol.
– volume: 234
  start-page: 375
  year: 2014
  end-page: 385
  ident: bb0100
  article-title: NF-kappaB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis
  publication-title: J. Pathol.
– volume: 2014
  start-page: 790902
  year: 2014
  ident: bb0130
  article-title: Hyperglycemia induces toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy
  publication-title: J. Diabetes Res.
– volume: 15
  start-page: 539
  year: 1998
  end-page: 553
  ident: bb0065
  article-title: Definition, diagnosis and classification of diabetes mellitus and its complications. part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
  publication-title: Diabet. Med.
– volume: 99
  start-page: 137
  year: 2015
  end-page: 148
  ident: bb0015
  article-title: Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy
  publication-title: Pharmacol. Res.
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  ident: bb0075
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
– volume: 62
  start-page: 879
  year: 2015
  end-page: 885
  ident: bb0060
  article-title: Serum fetuin-A concentrations are positively associated with serum VEGF levels in patients with newly diagnosed type 2 diabetes
  publication-title: Endocr. J.
– volume: 24
  start-page: 969
  year: 2007
  end-page: 976
  ident: bb0010
  article-title: Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in type 2 diabetes
  publication-title: Diabet. Med.
– volume: 18
  start-page: 160
  year: 2013
  end-page: 164
  ident: bb0105
  article-title: Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes
  publication-title: Biomarkers
– volume: 21
  start-page: 1839
  year: 2015
  end-page: 1842
  ident: bb0120
  article-title: Relation of serum and vitreous concentrations of fetuin-A with diabetic retinopathy
  publication-title: Med. Sci. Monit.
– volume: 57
  start-page: 1057
  year: 2014
  end-page: 1066
  ident: bb0055
  article-title: Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells
  publication-title: Diabetologia
– volume: 18
  start-page: 1279
  year: 2012
  end-page: 1285
  ident: bb0135
  article-title: Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
  publication-title: Nat. Med.
– volume: 10
  start-page: 185
  year: 2010
  end-page: 192
  ident: bb0030
  article-title: Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy
  publication-title: Clin. Exp. Med.
– volume: 57
  start-page: 1057
  year: 2014
  ident: 10.1016/j.cca.2016.02.003_bb0055
  article-title: Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells
  publication-title: Diabetologia
  doi: 10.1007/s00125-014-3177-0
– volume: 99
  start-page: 137
  year: 2015
  ident: 10.1016/j.cca.2016.02.003_bb0015
  article-title: Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2015.05.013
– volume: 24
  start-page: 969
  year: 2007
  ident: 10.1016/j.cca.2016.02.003_bb0010
  article-title: Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in type 2 diabetes
  publication-title: Diabet. Med.
  doi: 10.1111/j.1464-5491.2007.02217.x
– volume: 8
  start-page: 991
  year: 2015
  ident: 10.1016/j.cca.2016.02.003_bb0155
  article-title: Association of plasma fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus
  publication-title: Int. J. Clin. Exp. Med.
– volume: 9
  start-page: 777
  year: 2005
  ident: 10.1016/j.cca.2016.02.003_bb0020
  article-title: Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF)
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/j.1582-4934.2005.tb00379.x
– volume: 18
  start-page: 163
  year: 2010
  ident: 10.1016/j.cca.2016.02.003_bb0070
  article-title: Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition
  publication-title: Zhonghua Gan Zang Bing Za Zhi
– volume: 34
  start-page: 156
  year: 2011
  ident: 10.1016/j.cca.2016.02.003_bb0110
  article-title: Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease
  publication-title: Diabetes Care
  doi: 10.2337/dc10-0788
– volume: 63
  start-page: 773
  year: 2014
  ident: 10.1016/j.cca.2016.02.003_bb0160
  article-title: Circulating alanine transaminase (ALT) and gamma-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus metabolism study
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2014.03.008
– volume: 30
  start-page: 343
  year: 2011
  ident: 10.1016/j.cca.2016.02.003_bb0025
  article-title: Inflammation in diabetic retinopathy
  publication-title: Prog. Retin. Eye Res.
  doi: 10.1016/j.preteyeres.2011.05.002
– volume: 28
  start-page: 412
  year: 1985
  ident: 10.1016/j.cca.2016.02.003_bb0075
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 148
  start-page: 883
  year: 2009
  ident: 10.1016/j.cca.2016.02.003_bb0085
  article-title: Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy
  publication-title: Am J. Ophthalmol.
  doi: 10.1016/j.ajo.2009.07.007
– volume: 14
  start-page: 148
  year: 2007
  ident: 10.1016/j.cca.2016.02.003_bb0145
  article-title: A community-based study of the relationship between insulin resistance/beta-cell dysfunction and diabetic retinopathy among type II diabetics in Kinmen, Taiwan
  publication-title: Ophthalmic Epidemiol.
  doi: 10.1080/09286580601139220
– volume: 18
  start-page: 160
  year: 2013
  ident: 10.1016/j.cca.2016.02.003_bb0105
  article-title: Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes
  publication-title: Biomarkers
  doi: 10.3109/1354750X.2012.762806
– volume: 32
  start-page: 299
  year: 2009
  ident: 10.1016/j.cca.2016.02.003_bb0140
  article-title: Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients
  publication-title: Hypertens. Res.
  doi: 10.1038/hr.2009.8
– volume: 83
  start-page: 473
  year: 2006
  ident: 10.1016/j.cca.2016.02.003_bb0080
  article-title: Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors
  publication-title: Exp. Eye Res.
  doi: 10.1016/j.exer.2006.01.016
– volume: 234
  start-page: 375
  year: 2014
  ident: 10.1016/j.cca.2016.02.003_bb0100
  article-title: NF-kappaB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis
  publication-title: J. Pathol.
  doi: 10.1002/path.4403
– volume: 21
  start-page: 1839
  year: 2015
  ident: 10.1016/j.cca.2016.02.003_bb0120
  article-title: Relation of serum and vitreous concentrations of fetuin-A with diabetic retinopathy
  publication-title: Med. Sci. Monit.
  doi: 10.12659/MSM.893403
– volume: 15
  start-page: 539
  year: 1998
  ident: 10.1016/j.cca.2016.02.003_bb0065
  article-title: Definition, diagnosis and classification of diabetes mellitus and its complications. part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
  publication-title: Diabet. Med.
  doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
– volume: 53
  start-page: 4323
  year: 2012
  ident: 10.1016/j.cca.2016.02.003_bb0040
  article-title: Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.11-9119
– volume: 36
  start-page: 1222
  year: 2013
  ident: 10.1016/j.cca.2016.02.003_bb0125
  article-title: Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study
  publication-title: Diabetes Care
  doi: 10.2337/dc12-1591
– volume: 29
  start-page: 853
  year: 2006
  ident: 10.1016/j.cca.2016.02.003_bb0150
  article-title: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans
  publication-title: Diabetes Care
  doi: 10.2337/diacare.29.04.06.dc05-1938
– volume: 445
  start-page: 133
  year: 2015
  ident: 10.1016/j.cca.2016.02.003_bb0115
  article-title: Both diabetes and fetuin-A are independently associated with increased risk of arterial stiffness
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2015.03.030
– volume: 80
  start-page: 247
  year: 2006
  ident: 10.1016/j.cca.2016.02.003_bb0090
  article-title: Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.1205718
– volume: 7
  start-page: 1445
  year: 1993
  ident: 10.1016/j.cca.2016.02.003_bb0045
  article-title: Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level
  publication-title: Mol. Endocrinol.
– volume: 12
  start-page: 3315
  year: 2015
  ident: 10.1016/j.cca.2016.02.003_bb0095
  article-title: Inflammation and oxidative stress, rather than hypoxia, are predominant factors promoting angiogenesis in the initial phases of atherosclerosis
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2015.3800
– volume: 2014
  start-page: 790902
  year: 2014
  ident: 10.1016/j.cca.2016.02.003_bb0130
  article-title: Hyperglycemia induces toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy
  publication-title: J. Diabetes Res.
  doi: 10.1155/2014/790902
– volume: 10
  start-page: 185
  year: 2010
  ident: 10.1016/j.cca.2016.02.003_bb0030
  article-title: Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy
  publication-title: Clin. Exp. Med.
  doi: 10.1007/s10238-009-0084-7
– volume: 30
  start-page: 1272
  year: 2013
  ident: 10.1016/j.cca.2016.02.003_bb0005
  article-title: Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review
  publication-title: Diabet. Med.
  doi: 10.1111/dme.12274
– volume: 3
  year: 2008
  ident: 10.1016/j.cca.2016.02.003_bb0050
  article-title: Fetuin-A induces cytokine expression and suppresses adiponectin production
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0001765
– volume: 18
  start-page: 1279
  year: 2012
  ident: 10.1016/j.cca.2016.02.003_bb0135
  article-title: Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
  publication-title: Nat. Med.
  doi: 10.1038/nm.2851
– volume: 62
  start-page: 879
  year: 2015
  ident: 10.1016/j.cca.2016.02.003_bb0060
  article-title: Serum fetuin-A concentrations are positively associated with serum VEGF levels in patients with newly diagnosed type 2 diabetes
  publication-title: Endocr. J.
  doi: 10.1507/endocrj.EJ15-0152
– volume: 14
  start-page: 376
  year: 2014
  ident: 10.1016/j.cca.2016.02.003_bb0035
  article-title: Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema
  publication-title: Curr. Mol. Med.
  doi: 10.2174/1566524014666140128114414
SSID ssj0004061
Score 2.282261
Snippet The higher expression of vascular endothelial growth factor (VEGF) and C-reactive protein (CRP) is associated with the development of diabetic retinopathy (DR)...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 113
SubjectTerms Aged
alpha-2-HS-Glycoprotein - metabolism
C-reactive protein
C-Reactive Protein - metabolism
Diabetes Mellitus, Type 2 - complications
Diabetic Nephropathies
Diabetic retinopathy
Female
Fetuin-A
Humans
Male
Middle Aged
Type 2 diabetes mellitus
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - blood
Title Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy
URI https://dx.doi.org/10.1016/j.cca.2016.02.003
https://www.ncbi.nlm.nih.gov/pubmed/26851648
https://www.proquest.com/docview/1774157915
Volume 455
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61Wwm4ICiv5VEZiRNSqGM7Dx9XK6oF1J6o1FuU-IGCUm_VzR564Wf193UmThZxaA8c83CcZCbjL_Y38wF8ktorJ1KVUN5ionxjk1Jzm8jMGS9FXfKBTXh6lq_O1feL7GIPllMuDNEqx9gfY_oQrcc9x-PbPL5qW8rx5SR-mKZD1ai83IcDIXWezeBg8e3H6uxveiTP00lQjRpMi5sDzQufgAheeazcKe8bnu6Dn8MwdPIMno74kS3iLT6HPRcO4fFykm07hEen42r5C7jFQLC9ZN712zYkC9YRQWjD6mvH2p36bd_dMEMSHR2iTstoXpZN9FSGZ1CGVodOyn7hDzseiwI9rA6WLRNEnEO8ZEO5hzbglUKkew7ujN0wmuNlgsU53tawsZDrJva0203JlGFN-sg3L-H85OvP5SoZdRoSIzPZo5ktLfdJrtKi4EYb16jMOuXyprTaNoqq2Ftfe-8dz0QjvdWll4hEhRFFreQrmIV1cG-ACWW00l7oVCLUMblOLXeyrAtjMbCUxRz4ZJ7KjEXMSUujqya22u8KLVqRRSsuqPLpHD7vmlzFCh4Pnawmm1f_uGGFI8xDzT5O_lGhuWnNpQ5uvd1U-EYQIhU6zebwOjrO7i5EjnA3V-Xb_-v0HTyhrUgjeg-z_nrrPiBC6psj2P_yJz0av4M7_eYRnQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkSgXBOW1PI3ECSnUsZ2Hj9WKaoFuT63Um5X4gVIFb9XNHnrpz-rvY8ZOFnFoD1wTJ7Y8k_EX-5v5CPkslJeO5zLDvMVM-tZmtWI2E4UzXvCmZpFNuDwpF2fyx3lxvkPmUy4M0irH2J9ieozW45WDcTYPLrsOc3wZih_meawaVdYPyENZiAp5fV9v_vI8cMWa5NSw-XS0GUleMH6kd5Wpbqe4a3G6C3zGRejoKXkyokd6mAb4jOy4sE_25pNo2z55tBzPyp-TWwgDm9_Uu2HTheyQ9kgPWtPmytFuq3079NfUoEBHD5jTUtyVpRM5lUILzM_qwUXpL_hdh3tJnoc2wdJ5BngzRksaiz10Ad4UEtkzOjN0Q3GHl3Kadng7Q8cyruvU0_YyplKGFaojX78gZ0ffTueLbFRpyIwoxABGtnjYJ5jMq4oZZVwrC-ukK9vaKttKrGFvfeO9d6zgrfBW1V4ADuWGV40UL8luWAX3mlAujZLKc5ULADqmVLllTtRNZSyElbqaETaZR5uxhDkqafR64qpdaLCoRotqxrHu6Yx82T5ymep33NdYTjbX_zihhvXlvsc-Tf6hwdx44tIEt9qsNcwIAKRK5cWMvEqOsx0FLwHslrJ-83-dfiR7i9PlsT7-fvLzLXmMdxKh6B3ZHa427j1gpaH9EL-FP1WoEmg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+fetuin-A+levels+are+independently+correlated+with+vascular+endothelial+growth+factor+and+C-reactive+protein+concentrations+in+type+2+diabetic+patients+with+diabetic+retinopathy&rft.jtitle=Clinica+chimica+acta&rft.au=Zhou%2C+Zhong-Wei&rft.au=Ju%2C+Hui-Xiang&rft.au=Sun%2C+Ming-Zhong&rft.au=Fu%2C+Qing-Ping&rft.date=2016-04-01&rft.issn=1873-3492&rft.eissn=1873-3492&rft.volume=455&rft.spage=113&rft_id=info:doi/10.1016%2Fj.cca.2016.02.003&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-8981&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-8981&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-8981&client=summon